-
1
-
-
14744276712
-
Selective small molecules blocking HIV-1 Tat and coactivator PCAF association
-
Zeng L, Li J, Muller M et al. Selective small molecules blocking HIV-1 Tat and coactivator PCAF association. J. Am. Chem. Soc. 127(8), 2376-2377 (2005
-
(2005)
J. Am. Chem. Soc
, vol.127
, Issue.8
, pp. 2376-2377
-
-
Zeng, L.1
Li, J.2
Muller, M.3
-
2
-
-
30744456492
-
Target structure-based discovery of small molecules that block human p53 and CREB binding protein association
-
Sachchidanand, Resnick-Silverman L, Yan S et al. Target structure-based discovery of small molecules that block human p53 and CREB binding protein association. Chem. Biol. 13(1), 81-90 (2006
-
(2006)
Chem. Biol
, vol.13
, Issue.1
, pp. 81-90
-
-
Sachchidanand Resnick-Silverman, L.1
Yan, S.2
-
3
-
-
78650806593
-
Suppression of inflammation by a synthetic histone mimic
-
Nicodeme E, Jeffrey KL, Schaefer U et al. Suppression of inflammation by a synthetic histone mimic. Nature 468(7327), 1119-1123 (2010
-
(2010)
Nature
, vol.468
, Issue.7327
, pp. 1119-1123
-
-
Nicodeme, E.1
Jeffrey, K.L.2
Schaefer, U.3
-
4
-
-
79958078949
-
Discovery and characterization of small molecule inhibitors of the BET family bromodomains
-
Chung C-W, Coste H, White JH et al. Discovery and characterization of small molecule inhibitors of the BET family bromodomains. J. Med. Chem. 54(11), 3827-3838 (2011
-
(2011)
J. Med. Chem
, vol.54
, Issue.11
, pp. 3827-3838
-
-
Chung, C.-W.1
Coste, H.2
White, J.H.3
-
5
-
-
77952713824
-
RVX-208: A small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivo
-
Bailey D, Jahagirdar R, Gordon A et al. RVX-208: A small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivo. J. Am. Coll. Cardiol. 55(23), 2580-2589 (2010
-
(2010)
J. Am. Coll. Cardiol
, vol.55
, Issue.23
, pp. 2580-2589
-
-
Bailey, D.1
Jahagirdar, R.2
Gordon, A.3
-
6
-
-
84877085080
-
In vitro biosynthesis, isolation, and identification of predominant metabolites of 2-(4-(2-hydroxyethoxy)-3,5-dimethylphenyl)-5,7- dimethoxyquinazolin-4(3H)-one (RVX-208
-
Khmelnitsky YL, Mozhaev VV, Cotterill IC et al. In vitro biosynthesis, isolation, and identification of predominant metabolites of 2-(4-(2- hydroxyethoxy)-3,5-dimethylphenyl)-5,7-dimethoxyquinazolin-4(3H)-one (RVX-208). Eur. J. Med. Chem. 64C, 121-128 (2013
-
(2013)
Eur. J. Med. Chem. 64C
, pp. 121-128
-
-
Khmelnitsky, Y.L.1
Mozhaev, V.V.2
Cotterill, I.C.3
-
7
-
-
78650847770
-
Selective inhibition of BET bromodomains
-
Filippakopoulos P, Qi J, Picaud S et al. Selective inhibition of BET bromodomains. Nature 468(7327), 1067-1073 (2010
-
(2010)
Nature
, vol.468
, Issue.7327
, pp. 1067-1073
-
-
Filippakopoulos, P.1
Qi, J.2
Picaud, S.3
-
8
-
-
84893189613
-
The BRD-inhibitor OTX015 shows pre-clinical activity in diffuse large B-cell lymphoma (DLBCL
-
Bonetti P, Ponzoni M, Tibiletti MG et al. The BRD-inhibitor OTX015 shows pre-clinical activity in diffuse large B-cell lymphoma (DLBCL). Eur. J. Cancer. 48(Suppl. 6), 163-163 (2012
-
(2012)
Eur. J. Cancer
, vol.48
, Issue.SUPPL. 6
, pp. 163-163
-
-
Bonetti, P.1
Ponzoni, M.2
Tibiletti, M.G.3
-
9
-
-
84893160224
-
The BRD-inhibitor OTX015 is active in pre-clinical models of mature B-cell lymphoid tumors
-
abstract 1657
-
Bonetti P, Boi M, Ponzoni M et al. The BRD-inhibitor OTX015 is active in pre-clinical models of mature B-cell lymphoid tumors. Blood 120(21), abstract 1657 (2012
-
(2012)
Blood
, vol.120
, Issue.21
-
-
Bonetti, P.1
Boi, M.2
Ponzoni, M.3
-
10
-
-
84886276286
-
The BRD-inhibitor OTX015 shows pre-clinical activity in anaplastic large T-cell lymphoma (ALCL
-
abstract 4872
-
Boi M, Bonetti P, Ponzoni M et al. The BRD-inhibitor OTX015 shows pre-clinical activity in anaplastic large T-cell lymphoma (ALCL). Blood 120(21), abstract 4872 (2012
-
(2012)
Blood
, vol.120
, Issue.21
-
-
Boi, M.1
Bonetti, P.2
Ponzoni, M.3
-
11
-
-
80054984945
-
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukemia
-
Dawson MA, Prinjha RK, Dittmann A et al. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukemia. Nature 478(7370), 529-533 (2011
-
(2011)
Nature
, vol.478
, Issue.7370
, pp. 529-533
-
-
Dawson, M.A.1
Prinjha, R.K.2
Dittmann, A.3
-
12
-
-
84856397832
-
Fragment-based discovery of bromodomain inhibitors part 1: Inhibitor binding modes and implications for lead discovery
-
Chung C-W, Dean AW, Woolven JM, Bamborough P. Fragment-based discovery of bromodomain inhibitors part 1: Inhibitor binding modes and implications for lead discovery. J. Med. Chem. 55(2), 576-586 (2012
-
(2012)
J. Med. Chem
, vol.55
, Issue.2
, pp. 576-586
-
-
Chung, C.-W.1
Dean, A.W.2
Woolven, J.M.3
Bamborough, P.4
-
13
-
-
84856399470
-
Fragment-based discovery of bromodomain inhibitors part 2: Optimization of phenylisoxazole sulfonamides
-
Bamborough P, Diallo H, Goodacre JD et al. Fragment-based discovery of bromodomain inhibitors part 2: Optimization of phenylisoxazole sulfonamides. J. Med. Chem. 55(2), 587-596 (2012
-
(2012)
J. Med. Chem
, vol.55
, Issue.2
, pp. 587-596
-
-
Bamborough, P.1
Diallo, H.2
Goodacre, J.D.3
-
14
-
-
80053924872
-
3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands
-
Hewings DS, Wang M, Philpott M et al. 3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands. J. Med. Chem. 54(19), 6761-6770 (2011
-
(2011)
J. Med. Chem
, vol.54
, Issue.19
, pp. 6761-6770
-
-
Hewings, D.S.1
Wang, M.2
Philpott, M.3
-
15
-
-
84871738620
-
The design and synthesis of 5 and 6-isoxazolylbenzimidazoles as selective inhibitors of the BET bromodomains
-
Hay D, Fedorov O, Filippakopoulos P et al. The design and synthesis of 5 and 6-isoxazolylbenzimidazoles as selective inhibitors of the BET bromodomains. Med. Chem. Commun. 4, 140-144 (2013
-
(2013)
Med. Chem. Commun
, vol.4
, pp. 140-144
-
-
Hay, D.1
Fedorov, O.2
Filippakopoulos, P.3
-
16
-
-
84876833549
-
Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands
-
Hewings DS, Fedorov O, Filippakopoulos P et al. Optimization of 3,5-dimethylisoxazole derivatives as potent bromodomain ligands. J. Med. Chem. 56(8), 3217-3227 (2013
-
(2013)
J. Med. Chem
, vol.56
, Issue.8
, pp. 3217-3227
-
-
Hewings, D.S.1
Fedorov, O.2
Filippakopoulos, P.3
-
17
-
-
84870046749
-
Identification of a chemical probe for bromo and extra c-Terminal bromodomain inhibition through optimization of a fragment-derived hit
-
Fish PV, Filippakopoulos P, Bish G et al. Identification of a chemical probe for bromo and extra c-Terminal bromodomain inhibition through optimization of a fragment-derived hit. J. Med. Chem. 55(22), 9831-9837 (2012
-
(2012)
J. Med. Chem
, vol.55
, Issue.22
, pp. 9831-9837
-
-
Fish, P.V.1
Filippakopoulos, P.2
Bish, G.3
-
18
-
-
84878029292
-
Fragment-based drug discovery of 2-Thiazolidinones as inhibitors of the histone reader BRD4 bromodomain
-
Zhao L, Cao D, Chen T et al. Fragment-based drug discovery of 2-Thiazolidinones as inhibitors of the histone reader BRD4 bromodomain. J. Med. Chem. 56(10), 3833-3851 (2013
-
(2013)
J. Med. Chem
, vol.56
, Issue.10
, pp. 3833-3851
-
-
Zhao, L.1
Cao, D.2
Chen, T.3
-
19
-
-
83455202613
-
Progress in the discovery of small-molecule inhibitors of bromodomain-histone interactions
-
Chung C-W, Witherington J. Progress in the discovery of small-molecule inhibitors of bromodomain-histone interactions. J. Biomol. Screen. 16(10), 1170-1185 (2011
-
(2011)
J. Biomol. Screen
, vol.16
, Issue.10
, pp. 1170-1185
-
-
Chung, C.-W.1
Witherington, J.2
-
20
-
-
84871420585
-
Bromodomains: A new target class for small molecule drug discovery
-
Chung C-W, Tough DF. Bromodomains: A new target class for small molecule drug discovery. Drug Discov. Today: Ther. Strateg. 9,(2-3), e111-e120 (2012
-
(2012)
Drug Discov. Today: Ther. Strateg
, vol.9
, Issue.2-3
-
-
Chung, C.-W.1
Tough, D.F.2
-
21
-
-
84862817809
-
Place your BETs: The therapeutic potential of bromodomains
-
Prinjha RK, Witherington J, Lee K. Place your BETs: The therapeutic potential of bromodomains. Trends Pharmacol. Sci. 33(3), 146-153 (2012
-
(2012)
Trends Pharmacol. Sci
, vol.33
, Issue.3
, pp. 146-153
-
-
Prinjha, R.K.1
Witherington, J.2
Lee, K.3
-
22
-
-
84866353161
-
Bromodomains: Are readers right for epigenetic therapy?
-
Conway SJ. Bromodomains: Are readers right for epigenetic therapy? ACS Med. Chem. Lett. 3, 691-694 (2012
-
(2012)
ACS Med. Chem. Lett
, vol.3
, pp. 691-694
-
-
Conway, S.J.1
-
23
-
-
84860371953
-
Epigenetic protein families: A new frontier for drug discovery
-
Arrowsmith CH, Bountra C, Fish PV, Lee K, Schapira M. Epigenetic protein families: A new frontier for drug discovery. Nat. Rev. Drug Disc. 11(5), 384-400 (2012
-
(2012)
Nat. Rev. Drug Disc
, vol.11
, Issue.5
, pp. 384-400
-
-
Arrowsmith, C.H.1
Bountra, C.2
Fish, P.V.3
Lee, K.4
Schapira, M.5
-
24
-
-
84870013141
-
Progress in the development and application of small molecule inhibitors of bromodomain-Acetyl-lysine interactions
-
Hewings DS, Rooney TPC, Jennings LE et al. Progress in the development and application of small molecule inhibitors of bromodomain-Acetyl-lysine interactions. J. Med. Chem. 55(22), 9393-9413 (2012
-
(2012)
J. Med. Chem
, vol.55
, Issue.22
, pp. 9393-9413
-
-
Hewings, D.S.1
Rooney, T.P.C.2
Jennings, L.E.3
-
25
-
-
84857331171
-
Inhibition of bromodomain-mediated protein-protein interactions as a novel therapeutic strategy
-
Furdas SD, Carlino L, Sippl W, Jung M. Inhibition of bromodomain-mediated protein-protein interactions as a novel therapeutic strategy. Med. Chem. Commun. 3(2), 123-134 (2012
-
(2012)
Med. Chem. Commun
, vol.3
, Issue.2
, pp. 123-134
-
-
Furdas, S.D.1
Carlino, L.2
Sippl, W.3
Jung, M.4
-
26
-
-
77951218846
-
Structural basis for acetylated histone H4 recognition by the human BRD2 bromodomain
-
Umehara T, Nakamura Y, Jang MK et al. Structural basis for acetylated histone H4 recognition by the human BRD2 bromodomain. J. Biol. Chem. 285(10), 7610-7618 (2010
-
(2010)
J. Biol. Chem
, vol.285
, Issue.10
, pp. 7610-7618
-
-
Umehara, T.1
Nakamura, Y.2
Jang, M.K.3
-
27
-
-
84859443655
-
From ApoA1 upregulation to BET family bromodomain inhibition: Discovery of I-BET151
-
Mirguet O, Lamotte Y, Donche F et al. From ApoA1 upregulation to BET family bromodomain inhibition: Discovery of I-BET151. Bioorg. Med. Chem. Lett. 22(8), 2963-2967 (2012
-
(2012)
Bioorg. Med. Chem. Lett
, vol.22
, Issue.8
, pp. 2963-2967
-
-
Mirguet, O.1
Lamotte, Y.2
Donche, F.3
-
28
-
-
84862809749
-
Identification of a novel series of BET family bromodomain inhibitors: Binding mode and profile of I-BET151 (GSK1210151A
-
Seal J, Lamotte Y, Donche F et al. Identification of a novel series of BET family bromodomain inhibitors: Binding mode and profile of I-BET151 (GSK1210151A). Bioorg. Med. Chem. Lett. 22(8), 2968-2972 (2012
-
(2012)
Bioorg. Med. Chem. Lett
, vol.22
, Issue.8
, pp. 2968-2972
-
-
Seal, J.1
Lamotte, Y.2
Donche, F.3
-
29
-
-
84896692123
-
Naphthyridines as novel BET family bromodomain inhibitors
-
doi:10.1002/cmdc.201300259 Epub ahead of print
-
Mirguet O, Lamotte Y, Chung C-W et al. Naphthyridines as novel BET family bromodomain inhibitors. ChemMedChem doi:10.1002/cmdc.201300259 (2013) (Epub ahead of print
-
(2013)
Chem Med Chem
-
-
Mirguet, O.1
Lamotte, Y.2
Chung, C.-W.3
-
30
-
-
84859181036
-
Histone recognition and large-scale structural analysis of the human bromodomain family
-
Filippakopoulos P, Picaud S, Mangos M et al. Histone recognition and large-scale structural analysis of the human bromodomain family. Cell 149(1), 214-231 (2012
-
(2012)
Cell
, vol.149
, Issue.1
, pp. 214-231
-
-
Filippakopoulos, P.1
Picaud, S.2
Mangos, M.3
-
31
-
-
84901196606
-
Epigenetic drugs that do not target enzyme activity
-
doi:10.1016-j.ddtec.10.008 In press
-
Owen DR, Trzupek JD. Epigenetic drugs that do not target enzyme activity. Drug Discov. Today Technol. doi:10.1016-j.ddtec.10.008 (2012) (In press
-
(2012)
Drug Discov. Today Technol
-
-
Owen, D.R.1
Trzupek, J.D.2
-
32
-
-
69849089425
-
Synthesis at the interface of chemistry and biology
-
Wu X, Schultz PG. Synthesis at the interface of chemistry and biology. J. Am. Chem. Soc. 131(35), 12497-12515 (2009
-
(2009)
J. Am. Chem. Soc
, vol.131
, Issue.35
, pp. 12497-12515
-
-
Wu, X.1
Schultz, P.G.2
-
33
-
-
84857913614
-
Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family
-
Filippakopoulos P, Picaud S, Fedorov O et al. Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family. Bioorg. Med. Chem. 20(6), 1878-1886 (2012
-
(2012)
Bioorg. Med. Chem
, vol.20
, Issue.6
, pp. 1878-1886
-
-
Filippakopoulos, P.1
Picaud, S.2
Fedorov, O.3
-
34
-
-
0033519641
-
JE, Zeng L, He C, Aggarwal AK, Zhou MM. Structure and ligand of a histone acetyltransferase bromodomain
-
Carlson
-
Dhalluin C, Carlson JE, Zeng L, He C, Aggarwal AK, Zhou MM. Structure and ligand of a histone acetyltransferase bromodomain. Nature 399(6735), 491-496 (1999
-
(1999)
Nature
, vol.399
, Issue.6735
, pp. 491-496
-
-
Dhalluin, C.1
-
35
-
-
0036206045
-
Structural basis of lysine-Acetylated HIV-1 Tat recognition by PCAF bromodomain
-
Mujtaba S, He Y, Zeng L et al. Structural basis of lysine-Acetylated HIV-1 Tat recognition by PCAF bromodomain. Mol. Cell. 9(3), 575-586 (2002
-
(2002)
Mol. Cell
, vol.9
, Issue.3
, pp. 575-586
-
-
Mujtaba, S.1
He, Y.2
Zeng, L.3
-
36
-
-
34249027590
-
Structure-guided optimization of small molecules inhibiting human immunodeficiency virus 1 Tat association with the human coactivator p300/CREB binding protein-Associated factor
-
Pan C, Mezei M, Mujtaba S et al. Structure-guided optimization of small molecules inhibiting human immunodeficiency virus 1 Tat association with the human coactivator p300/CREB binding protein-Associated factor. J. Med. Chem. 50(10), 2285-2288 (2007
-
(2007)
J. Med. Chem
, vol.50
, Issue.10
, pp. 2285-2288
-
-
Pan, C.1
Mezei, M.2
Mujtaba, S.3
-
37
-
-
84876713208
-
Small organic molecules targeting PCAF bromodomain as potent inhibitors of HIV-1 replication
-
Wang Q, Wang R, Zhang B, Zhang S, Zheng Y, Wang Z. Small organic molecules targeting PCAF bromodomain as potent inhibitors of HIV-1 replication. Med. Chem. Commun. 4(4), 737-740 (2013
-
(2013)
Med. Chem. Commun
, vol.4
, Issue.4
, pp. 737-740
-
-
Wang, Q.1
Wang, R.2
Zhang, B.3
Zhang, S.4
Zheng, Y.5
Wang, Z.6
-
38
-
-
77449109789
-
Target gene context influences the transcriptional requirement for the KAT3 family of CBP and p300 histone acetyltransferases
-
Bedford DC, Kasper LH, Fukuyama T, Brindle PK. Target gene context influences the transcriptional requirement for the KAT3 family of CBP and p300 histone acetyltransferases. Epigenetics 5(1), 9-15 (2010
-
(2010)
Epigenetics
, vol.5
, Issue.1
, pp. 9-15
-
-
Bedford, D.C.1
Kasper, L.H.2
Fukuyama, T.3
Brindle, P.K.4
-
39
-
-
10744233648
-
Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation
-
Mujtaba S, He Y, Zeng L et al. Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation. Mol. Cell. 13(2), 251-263 (2004
-
(2004)
Mol. Cell
, vol.13
, Issue.2
, pp. 251-263
-
-
Mujtaba, S.1
He, Y.2
Zeng, L.3
-
40
-
-
79955410483
-
A small molecule binding to the coactivator CREB-binding protein blocks apoptosis in cardiomyocytes
-
Borah JC, Mujtaba S, Karakikes I et al. A small molecule binding to the coactivator CREB-binding protein blocks apoptosis in cardiomyocytes. Chem. Biol. 18(4), 531-541 (2011
-
(2011)
Chem. Biol
, vol.18
, Issue.4
, pp. 531-541
-
-
Borah, J.C.1
Mujtaba, S.2
Karakikes, I.3
-
41
-
-
84884238437
-
Discovery, design, and optimization of isoxazole azepine BET inhibitors
-
Gehling VS, Hewitt MC, Vaswani RG et al. Discovery, design, and optimization of isoxazole azepine BET inhibitors. ACS Med. Chem. Lett. 4(9), 835-840 (2013
-
(2013)
ACS Med. Chem. Lett
, vol.4
, Issue.9
, pp. 835-840
-
-
Gehling, V.S.1
Hewitt, M.C.2
Vaswani, R.G.3
-
42
-
-
80052728034
-
Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery
-
Philpott M, Yang J, Tumber T et al. Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery. Mol. BioSyst. 7(10), 2899-2908 (2011
-
(2011)
Mol. BioSyst
, vol.7
, Issue.10
, pp. 2899-2908
-
-
Philpott, M.1
Yang, J.2
Tumber, T.3
-
43
-
-
1942453243
-
Ligand efficiency: A useful metric for lead selection
-
Hopkins AL, Groom CR, Alex A. Ligand efficiency: A useful metric for lead selection. Drug Discov. Today. 9(10), 430-431 (2004
-
(2004)
Drug Discov. Today
, vol.9
, Issue.10
, pp. 430-431
-
-
Hopkins, A.L.1
Groom, C.R.2
Alex, A.3
-
44
-
-
84878565710
-
PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains
-
Picaud S, Da Costa D, Thanasopoulou A et al. PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains. Cancer Res. 73(11), 3336-3346 (2013
-
(2013)
Cancer Res
, vol.73
, Issue.11
, pp. 3336-3346
-
-
Picaud, S.1
Da Costa, D.2
Thanasopoulou, A.3
-
45
-
-
84886504602
-
Discovery of novel small-molecule inhibitors of BRD4 using structure-based virtual screening
-
Vidler LR, Filippakopoulos P, Fedorov O et al. Discovery of novel small-molecule inhibitors of BRD4 using structure-based virtual screening. J. Med. Chem. 56(20), 8073-8088 (2013
-
(2013)
J. Med. Chem
, vol.56
, Issue.20
, pp. 8073-8088
-
-
Vidler, L.R.1
Filippakopoulos, P.2
Fedorov, O.3
-
46
-
-
79953703975
-
Fragment screening to predict druggability (ligandability) and lead discovery success
-
Edfeldt FNB, Folmer RHA, Breeze AL. Fragment screening to predict druggability (ligandability) and lead discovery success. Drug Discov. Today 16(7-8), 284-287 (2011
-
(2011)
Drug Discov. Today
, vol.16
, Issue.7-8
, pp. 284-287
-
-
Edfeldt, F.N.B.1
Folmer, R.H.A.2
Breeze, A.L.3
-
47
-
-
79952005101
-
Efficacy and safety of a novel oral inducer of apolipoprotein a-I synthesis in statin-Treated patients with stable coronary artery disease a randomized controlled trial
-
Nicholls SJ, Gordon A, Johansson J et al. Efficacy and safety of a novel oral inducer of apolipoprotein a-I synthesis in statin-Treated patients with stable coronary artery disease a randomized controlled trial. J. Am. Coll. Cardiol. 57(9), 1111-1119 (2011
-
(2011)
J. Am. Coll. Cardiol
, vol.57
, Issue.9
, pp. 1111-1119
-
-
Nicholls, S.J.1
Gordon, A.2
Johansson, J.3
-
48
-
-
84862765834
-
ApoA-I induction as a potential cardioprotective strategy: Rationale for the SUSTAIN and ASSURE studies
-
Nicholls SJ, Gordon A, Johannson J et al. ApoA-I induction as a potential cardioprotective strategy: Rationale for the SUSTAIN and ASSURE studies. Cardiovasc Drugs Ther. 26(2), 181-187 (2012
-
(2012)
Cardiovasc Drugs Ther
, vol.26
, Issue.2
, pp. 181-187
-
-
Nicholls, S.J.1
Gordon, A.2
Johannson, J.3
-
49
-
-
0026580006
-
Brahma: A regulator of Drosophila homeotic genes structurally related to the yeast transcriptional activator SNF2/SWI2
-
Tamkun JW, Deuring R, Scott MP et al. brahma: A regulator of Drosophila homeotic genes structurally related to the yeast transcriptional activator SNF2/SWI2. Cell 68(3), 561-572 (1992
-
(1992)
Cell
, vol.68
, Issue.3
, pp. 561-572
-
-
Tamkun, J.W.1
Deuring, R.2
Scott, M.P.3
-
50
-
-
0026608175
-
The bromodomain: A conserved sequence found in human, Drosophila and yeast proteins
-
Haynes SR, Dollard C, Winston F, Beck S, Trowsdale J, Dawid IB. The bromodomain: A conserved sequence found in human, Drosophila and yeast proteins. Nucleic Acids Res. 20(10), 2603 (1992
-
(1992)
Nucleic Acids Res
, vol.20
, Issue.10
, pp. 2603
-
-
Haynes, S.R.1
Dollard, C.2
Winston, F.3
Beck, S.4
Trowsdale, J.5
Dawid, I.B.6
-
51
-
-
17444386662
-
The bromodomain: A chromatin-Targeting module?
-
Winston F, Allis C. The bromodomain: A chromatin-Targeting module? Nat. Struct. Biol. 6(7), 601-604 (1999
-
(1999)
Nat. Struct. Biol
, vol.6
, Issue.7
, pp. 601-604
-
-
Winston, F.1
Allis, C.2
-
52
-
-
84859926557
-
Small molecule bromodomain inhibitors: Extending the druggable genome
-
Chung C-W. Small molecule bromodomain inhibitors: Extending the druggable genome. Prog. Med. Chem. 51, 1-55 (2012
-
(2012)
Prog. Med. Chem
, vol.51
, pp. 1-55
-
-
Chung, C.-W.1
-
53
-
-
80055000824
-
RNAi screen identifies BRD4 as a therapeutic target in acute myeloid leukemia
-
Zuber J, Shi J, Wang E et al. RNAi screen identifies BRD4 as a therapeutic target in acute myeloid leukemia. Nature 478(7370), 524-528 (2011
-
(2011)
Nature
, vol.478
, Issue.7370
, pp. 524-528
-
-
Zuber, J.1
Shi, J.2
Wang, E.3
-
54
-
-
80053651202
-
Targeting MYC dependence in cancer by inhibiting BET bromodomains
-
Mertz JA, Conery AR, Bryant BM et al. Targeting MYC dependence in cancer by inhibiting BET bromodomains. Proc. Natl Acad. Sci. USA 108(40), 16669-16674 (2011
-
(2011)
Proc. Natl Acad. Sci. USA
, vol.108
, Issue.40
, pp. 16669-16674
-
-
Mertz, J.A.1
Conery, A.R.2
Bryant, B.M.3
-
55
-
-
70450169243
-
Inhibition of protein-protein interactions using designed molecules
-
Wilson AJ. Inhibition of protein-protein interactions using designed molecules. Chem. Soc. Rev. 38(12), 3289-3300 (2009
-
(2009)
Chem. Soc. Rev
, vol.38
, Issue.12
, pp. 3289-3300
-
-
Wilson, A.J.1
-
56
-
-
84866338076
-
Druggability analysis and structural classification of bromodomain acetyl-lysine binding sites
-
Vidler LR, Brown N, Knapp S, Hoelder S. Druggability analysis and structural classification of bromodomain acetyl-lysine binding sites. J. Med. Chem. 55(17), 7346-7359 (2012
-
(2012)
J. Med. Chem
, vol.55
, Issue.17
, pp. 7346-7359
-
-
Vidler, L.R.1
Brown, N.2
Knapp, S.3
Hoelder, S.4
-
57
-
-
84866314665
-
Scaling the druggability landscape of human bromodomains, a new class of drug targets
-
Zhang G, Sanchez R, Zhou M-M. Scaling the druggability landscape of human bromodomains, a new class of drug targets. J. Med. Chem. 55(17), 7342-7345 (2012
-
(2012)
J. Med. Chem
, vol.55
, Issue.17
, pp. 7342-7345
-
-
Zhang, G.1
Sanchez, R.2
Zhou, M.-M.3
-
59
-
-
84885675970
-
Discovery of epigenetic regulator I-BET762: Lead optimization to afford a clinical candidate inhibitor of the BET bromodomains
-
Mirguet O, Gosmini R, Toum J et al. Discovery of epigenetic regulator I-BET762: Lead optimization to afford a clinical candidate inhibitor of the BET bromodomains. J. Med. Chem. 56(19), 7501-7515 (2013
-
(2013)
J. Med. Chem
, vol.56
, Issue.19
, pp. 7501-7515
-
-
Mirguet, O.1
Gosmini, R.2
Toum, J.3
-
60
-
-
35748934487
-
The influence of drug-like concepts on decision-making in medicinal chemistry
-
Leeson PD, Springthorpe B. The influence of drug-like concepts on decision-making in medicinal chemistry. Nat. Rev. Drug Disc. 6(11), 881-890 (2007
-
(2007)
Nat. Rev. Drug Disc
, vol.6
, Issue.11
, pp. 881-890
-
-
Leeson, P.D.1
Springthorpe, B.2
-
61
-
-
84865229469
-
Small-molecule inhibition of BRDT for male contraception
-
Matzuk MM, McKeown MR, Filippakopoulos P et al. Small-molecule inhibition of BRDT for male contraception. Cell 150(4), 673-684 (2012
-
(2012)
Cell
, vol.150
, Issue.4
, pp. 673-684
-
-
Matzuk, M.M.1
McKeown, M.R.2
Filippakopoulos, P.3
-
62
-
-
84876033650
-
Targeting MYCN in neuroblastoma by BET bromodomain inhibition
-
Puissant A, Frumm SM, Alexe G et al. Targeting MYCN in neuroblastoma by BET bromodomain inhibition. Cancer Discov. 3(3), 308-323 (2013
-
(2013)
Cancer Discov
, vol.3
, Issue.3
, pp. 308-323
-
-
Puissant, A.1
Frumm, S.M.2
Alexe, G.3
-
63
-
-
84870708220
-
Stability of nucleosomes containing homogenously ubiquitylated H2A and H2B prepared using semisynthesis
-
Fierz B, Kilic S, Hieb AR, Luger K, Muir TW. Stability of nucleosomes containing homogenously ubiquitylated H2A and H2B prepared using semisynthesis. J. Am. Chem. Soc. 134(48), 19548-19551 (2012
-
(2012)
J. Am. Chem. Soc
, vol.134
, Issue.48
, pp. 19548-19551
-
-
Fierz, B.1
Kilic, S.2
Hieb, A.R.3
Luger, K.4
Muir, T.W.5
-
64
-
-
77954821594
-
What an epigenome remembers
-
Lange UC, Schneider R. What an epigenome remembers. Bioessays 32(8), 659-668 (2010
-
(2010)
Bioessays
, vol.32
, Issue.8
, pp. 659-668
-
-
Lange, U.C.1
Schneider, R.2
-
65
-
-
79956140184
-
Getting pharmaceutical R&D back on target
-
Bunnage ME. Getting pharmaceutical R&D back on target. Nat. Chem. Biol. 7(6), 335-339 (2011
-
(2011)
Nat. Chem. Biol
, vol.7
, Issue.6
, pp. 335-339
-
-
Bunnage, M.E.1
-
66
-
-
0037138363
-
Bromodomain: An acetyl-lysine binding domain
-
Zeng L, Zhou M. Bromodomain: An acetyl-lysine binding domain. FEBS Lett. 513(1), 124-128 (2002
-
(2002)
FEBS Lett
, vol.513
, Issue.1
, pp. 124-128
-
-
Zeng, L.1
Zhou, M.2
-
67
-
-
84864578590
-
The bromodomain interaction module
-
Filippakopoulos P, Knapp S. The bromodomain interaction module. FEBS Lett. 586(17), 2692-2704 (2012
-
(2012)
FEBS Lett
, vol.586
, Issue.17
, pp. 2692-2704
-
-
Filippakopoulos, P.1
Knapp, S.2
-
68
-
-
0016211838
-
Chromatin structure; oligomers of the histones
-
Kornberg RD, Thomas JO. Chromatin structure; oligomers of the histones. Science 184(4139), 865-868 (1974
-
(1974)
Science
, vol.184
, Issue.4139
, pp. 865-868
-
-
Kornberg, R.D.1
Thomas, J.O.2
-
69
-
-
0016221697
-
Chromatin structure: A repeating unit of histones and DNA
-
Kornberg RD. Chromatin structure: A repeating unit of histones and DNA. Science 184(4139), 868-871 (1974
-
(1974)
Science
, vol.184
, Issue.4139
, pp. 868-871
-
-
Kornberg, R.D.1
-
70
-
-
1842411320
-
Crystal structure of the nucleosome core particle at 2.8 Å resolution
-
Luger K, Mäder AW, Richmond RK, Sargent DF, Richmond TJ. Crystal structure of the nucleosome core particle at 2.8 Å resolution. Nature 389(6648), 251-260 (1997
-
(1997)
Nature
, vol.389
, Issue.6648
, pp. 251-260
-
-
Luger, K.1
Mäder, A.W.2
Richmond, R.K.3
Sargent, D.F.4
Richmond, T.J.5
-
71
-
-
78651162036
-
Acetylation and Methylation of Histones and their Possible Role in Regulation of RNA Synthesis
-
Allfrey V, Faulkner R, Mirsky A. Acetylation and Methylation of Histones and their Possible Role in Regulation of RNA Synthesis. Proc. Natl Acad. Sci. USA 51(5), 786-794 (1964
-
(1964)
Proc. Natl Acad. Sci. USA
, vol.51
, Issue.5
, pp. 786-794
-
-
Allfrey, V.1
Faulkner, R.2
Mirsky, A.3
-
72
-
-
0034610814
-
The language of covalent histone modifications
-
Strahl BD, Allis CD. The language of covalent histone modifications. Nature 403(6765), 41-45 (2000
-
(2000)
Nature
, vol.403
, Issue.6765
, pp. 41-45
-
-
Strahl, B.D.1
Allis, C.D.2
-
73
-
-
0033848849
-
Histone acetylation and an epigenetic code
-
Turner BM. Histone acetylation and an epigenetic code. Bioessays 22(9), 836-845 (2000
-
(2000)
Bioessays
, vol.22
, Issue.9
, pp. 836-845
-
-
Turner, B.M.1
-
74
-
-
0037074010
-
Signaling network model of chromatin
-
Schreiber SL, Bernstein BE. Signaling network model of chromatin. Cell 111(6), 771-778 (2002
-
(2002)
Cell
, vol.111
, Issue.6
, pp. 771-778
-
-
Schreiber, S.L.1
Bernstein, B.E.2
-
75
-
-
79955473684
-
Operating on chromatin, a colorful language where context matters
-
Gardner KE, Allis CD, Strahl BD. Operating on chromatin, a colorful language where context matters. J. Mol. Biol. 409(1), 36-46 (2011
-
(2011)
J. Mol. Biol
, vol.409
, Issue.1
, pp. 36-46
-
-
Gardner, K.E.1
Allis, C.D.2
Strahl, B.D.3
-
76
-
-
0030798245
-
Histone acetylation in chromatin structure and transcription
-
Grunstein M. Histone acetylation in chromatin structure and transcription. Nature 389(6649), 349-352 (1997
-
(1997)
Nature
, vol.389
, Issue.6649
, pp. 349-352
-
-
Grunstein, M.1
-
77
-
-
0035839136
-
Translating the histone code
-
Jenuwein T, Allis CD. Translating the histone code. Science 293(5532), 1074-1080 (2001
-
(2001)
Science
, vol.293
, Issue.5532
, pp. 1074-1080
-
-
Jenuwein, T.1
Allis, C.D.2
-
78
-
-
0036849072
-
Global approaches to chromatin
-
Bernstein BE, Schreiber SL. Global approaches to chromatin. Chem. Biol. 9(11), 1167-1173 (2002
-
(2002)
Chem. Biol
, vol.9
, Issue.11
, pp. 1167-1173
-
-
Bernstein, B.E.1
Schreiber, S.L.2
-
79
-
-
84865179248
-
The adjustable nucleosome: An epigenetic signaling module
-
Turner BM. The adjustable nucleosome: An epigenetic signaling module. Trends Genet. 28(9), 436-444 (2012
-
(2012)
Trends Genet
, vol.28
, Issue.9
, pp. 436-444
-
-
Turner, B.M.1
-
80
-
-
34249337761
-
Perceptions of epigenetics
-
Bird A. Perceptions of epigenetics. Nature 447(7143), 396-398 (2007
-
(2007)
Nature
, vol.447
, Issue.7143
, pp. 396-398
-
-
Bird, A.1
-
81
-
-
84876888289
-
Epigenetics: Core misconcept
-
Ptashne M. Epigenetics: Core misconcept. Proc. Natl Acad. Sci. USA 110(18), 7101-7103 (2013
-
(2013)
Proc. Natl Acad. Sci. USA
, vol.110
, Issue.18
, pp. 7101-7103
-
-
Ptashne, M.1
-
82
-
-
67049134843
-
How to achieve confidence in drug discovery and development: Managing risk (from a reductionist to a holistic approach
-
Bakker A, Caricasole A, Gaviraghi G et al. How to achieve confidence in drug discovery and development: Managing risk (from a reductionist to a holistic approach). ChemMedChem 4(6), 923-933 (2009
-
(2009)
ChemMedChem
, vol.4
, Issue.6
, pp. 923-933
-
-
Bakker, A.1
Caricasole, A.2
Gaviraghi, G.3
-
84
-
-
84881296154
-
Trial watch: Phase ii and phase iii attrition rates 2011-2012
-
Arrowsmith J, Miller P. Trial Watch: Phase II and Phase III attrition rates 2011-2012. Nat. Rev. Drug Disc. 12(8), 569 (2013
-
(2013)
Nat. Rev. Drug Disc
, vol.12
, Issue.8
, pp. 569
-
-
Arrowsmith, J.1
Miller, P.2
-
86
-
-
46849089254
-
Recent developments in fragment-based drug discovery
-
Congreve M, Chessari G, Tisi D, Woodhead AJ. Recent developments in fragment-based drug discovery. J. Med. Chem. 51(13), 3661-3680 (2008
-
(2008)
J. Med. Chem
, vol.51
, Issue.13
, pp. 3661-3680
-
-
Congreve, M.1
Chessari, G.2
Tisi, D.3
Woodhead, A.J.4
-
87
-
-
0141726877
-
A rule of threé for fragment-based lead discovery?
-
Congreve M, Carr R, Murray C, Jhoti H. A rule of threé for fragment-based lead discovery? Drug Discov. Today 8(19), 876-877 (2003
-
(2003)
Drug Discov. Today
, vol.8
, Issue.19
, pp. 876-877
-
-
Congreve, M.1
Carr, R.2
Murray, C.3
Jhoti, H.4
-
88
-
-
84862869077
-
Fragment-based approaches in drug discovery and chemical biology
-
Scott DE, Coyne AG, Hudson SA, Abell C. Fragment-based approaches in drug discovery and chemical biology. Biochemistry 51(25), 4990-5003 (2012
-
(2012)
Biochemistry
, vol.51
, Issue.25
, pp. 4990-5003
-
-
Scott, D.E.1
Coyne, A.G.2
Hudson, S.A.3
Abell, C.4
-
89
-
-
84874414338
-
Fragment-based lead discovery grows up
-
Baker M. Fragment-based lead discovery grows up. Nat. Rev. Drug Disc. 12(1), 5-7 (2013
-
(2013)
Nat. Rev. Drug Disc
, vol.12
, Issue.1
, pp. 5-7
-
-
Baker, M.1
-
90
-
-
84868475728
-
MicroRNA therapeutics for cardiovascular disease: Opportunities and obstacles
-
van Rooij E, Olson EN. MicroRNA therapeutics for cardiovascular disease: Opportunities and obstacles. Nat. Rev. Drug Disc. 11(11), 860-872 (2012
-
(2012)
Nat. Rev. Drug Disc
, vol.11
, Issue.11
, pp. 860-872
-
-
Van Rooij, E.1
Olson, E.N.2
|